-

RootPath Announces Presentation and Fireside Chat at Built With Biology 2022

WATERTOWN, Mass.--(BUSINESS WIRE)--RootPath, a synthetic biology company that elevates the throughput of gene function interrogation by orders of magnitude, today announced that CEO and Co-Founder, Xi Chen, will present an overview of RootPath’s gene synthesis platform PathFinder DNA Assembly™ and Nano Toothpick™ at the Built With Biology Conference on April 13, 2022 at 12:30 pm PDT in Oakland, California.

Susana Donkor, a research associate at RootPath, will participate in a fireside chat at the Built With Biology Conference on April 12, 2022 at 5:25 PM PDT.

About RootPath

RootPath is a synthetic biology company that elevates the throughput of gene function interrogation by orders of magnitude. Our Molecular Programming-based DNA fragment assembly technology gives researchers and drug developers unprecedented, equitable access to long synthetic genes and their functional readouts. By applying our technology to mine a patient’s immunome, we create truly personalized T cell therapies for solid tumors. Together, with leading partners, we are exploring new applications across multiple industries. We enable biology at scale.

Contacts

Media Contact:
Isabel Good
MacDougall Advisors
781-235-3060
igood@macdougall.bio

Industry:

RootPath

Release Versions
English

Contacts

Media Contact:
Isabel Good
MacDougall Advisors
781-235-3060
igood@macdougall.bio

More News From RootPath

RootPath Announces Data on Tumor Reactivity Through Its Proprietary Platform at the Society for Immunology of Cancer (SITC) 37th Annual Meeting

WATERTOWN, Mass.--(BUSINESS WIRE)--RootPath, a synthetic biology company that elevates the throughput of gene function interrogation by orders of magnitude, today announced the presentation of data on tumor reactivity in various applications via its PathFinder DNA AssemblyTM technology in three posters at the 37th Annual Meeting of the Society for Immunology of Cancer (SITC) in Boston, Massachusetts. “The posters that we are presenting at SITC continue to demonstrate the power of RootPath’s pla...

RootPath to Present at the Upcoming American Society of Gene & Cell Therapy Annual Meeting

WATERTOWN, Mass.--(BUSINESS WIRE)--RootPath, a synthetic biology company that elevates the throughput of gene function interrogation by orders of magnitude, today announced that a poster presentation highlighting its lead therapeutic candidates, a series of fully personalized T cell therapies, at the American Society of Gene & Cell Therapy (ASGCT) 25th Annual Meeting taking place May 16-19, 2022 in Washington, D.C. The details of the poster presentation are as follows: Abstract Title: Massi...

RootPath Launches, Elevating Throughput of Gene Function Interrogation by Orders of Magnitude

WATERTOWN, Mass.--(BUSINESS WIRE)--RootPath's lead therapeutic candidates, fully personalized T cell therapies to be presented at Keystone Symposium’s Cancer Immunotherapy...
Back to Newsroom